Does Wellbutrin (bupropion) affect tic disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Wellbutrin Affect Tic Disorders?

Yes, bupropion (Wellbutrin) can exacerbate tics in patients with existing tic disorders and has been reported to induce new-onset tics in susceptible individuals. 1, 2

Evidence of Tic Exacerbation

Multiple case reports and case series demonstrate that bupropion worsens tics in patients with pre-existing tic disorders:

  • A 1993 retrospective case series of four children with comorbid ADHD and Tourette syndrome showed that bupropion exacerbated tics in all patients, leading the authors to conclude that bupropion is not an appropriate alternative to stimulants in this population. 2

  • A 2019 case report documented tic exacerbation in an older adult with a known tic disorder that had been in remission but worsened during bupropion treatment. 1

  • Additional case reports from 2014 describe new-onset motor and vocal tics developing with bupropion XL use. 3

Mechanism and Clinical Context

The dopaminergic activity of bupropion likely underlies its potential to worsen tics, similar to other dopaminergic compounds like methylphenidate. 1 This is particularly relevant because:

  • Tic disorders (including Tourette syndrome) are treated with dopamine receptor-blocking drugs (neuroleptics), suggesting dopaminergic enhancement can worsen tics. 4

  • Bupropion acts as a dopamine and norepinephrine reuptake inhibitor, increasing dopaminergic neurotransmission. 5

Clinical Recommendations for ADHD with Comorbid Tic Disorders

When treating ADHD in patients with tic disorders, the evidence suggests a specific hierarchy:

First-line options:

  • Atomoxetine is positioned as a first-line option for comorbid ADHD and tic disorders because it has been shown not to worsen tics in clinical trials. 4
  • Alpha-2 agonists (clonidine or guanfacine) are also first-line options for comorbid tic/Tourette's disorder. 4

Stimulant considerations:

  • Recent controlled studies show that stimulants (particularly methylphenidate) do not worsen tics in the majority of patients with ADHD and comorbid tic disorders. 4, 6
  • Methylphenidate may be less likely to exacerbate tics than amphetamine-based medications. 7, 6
  • With proper informed consent, a stimulant trial can be undertaken; if tics worsen markedly, switch to an alternative. 4

Bupropion should be avoided:

  • Given the documented cases of tic exacerbation and the availability of safer alternatives (atomoxetine, alpha-2 agonists), bupropion is not recommended for patients with known tic disorders. 2

Important Caveats

  • The evidence base for bupropion-induced tic exacerbation consists primarily of case reports and small case series rather than large controlled trials. 1, 3, 2

  • However, one isolated case report suggests atomoxetine may also rarely be associated with new-onset tics, though this contradicts larger controlled trial data. 8

  • Clinicians prescribing bupropion to any patient should screen for personal or family history of tic disorders before initiating treatment. 1

References

Research

Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.

Journal of the American Academy of Child and Adolescent Psychiatry, 1993

Research

Bupropion XL-induced motor and vocal tics.

Clinical neuropharmacology, 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Adderall and Tic Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Tourette's Syndrome and Comorbid ADHD

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Atomoxetine use associated with onset of a motor tic.

Journal of child and adolescent psychopharmacology, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.